• Board allotted 52,900 equity shares under ESOP schemes, increasing paid-up capital to ₹82.49 crore.
• Approved fundraising up to ₹1,000 crore via non-convertible debentures, subject to shareholder approval.
• Disclosures made pursuant to SEBI Listing Regulations following board meeting on 7 May 2026.